Wanshili: Plans to establish a wholly-owned subsidiary in Macau

Wanshili Announcement: The company plans to establish Macau Mingyang Health Industry Co., Ltd. in Macau using its own funds. The main activities will include outsourcing processing, research and development, quality inspection, operation, and sales of Wanshili’s proprietary product “Wanshili Golden Silkworm No. 1,” which involves extracting protein peptides from silkworm pupae using Pickering self-assembly technology. The external investment plan over three years totals 25 million RMB, and the company will complete the ODI filing procedures. The first phase of investment is expected to be 10 million RMB, with additional investments gradually added over the next three years based on the actual operational needs of the Macau company.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin